Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Change in Acquisitions & Divestments (2016 - 2024)

Historic Change in Acquisitions & Divestments for Integra Lifesciences Holdings (IART) over the last 8 years, with Q4 2024 value amounting to $35.2 million.

  • Integra Lifesciences Holdings' Change in Acquisitions & Divestments changed N/A to $35.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $30.3 million, marking a year-over-year increase of 70864.59%. This contributed to the annual value of $54.5 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q4 2024, Integra Lifesciences Holdings' Change in Acquisitions & Divestments is $35.2 million.
  • In the past 5 years, Integra Lifesciences Holdings' Change in Acquisitions & Divestments ranged from a high of $35.2 million in Q4 2024 and a low of -$4.9 million during Q4 2022
  • Moreover, its 3-year median value for Change in Acquisitions & Divestments was $0.0 (2021), whereas its average is $7.6 million.
  • Examining YoY changes over the last 5 years, Integra Lifesciences Holdings' Change in Acquisitions & Divestments showed a top increase of 635921.05% in 2022 and a maximum decrease of 635921.05% in 2022.
  • Over the past 3 years, Integra Lifesciences Holdings' Change in Acquisitions & Divestments (Quarter) stood at -$76000.0 in 2021, then tumbled by 6359.21% to -$4.9 million in 2022, then surged by 818.07% to $35.2 million in 2024.
  • Its Change in Acquisitions & Divestments was $35.2 million in Q4 2024, compared to -$4.9 million in Q4 2022 and -$76000.0 in Q4 2021.